Material differentiation by dual energy CT: initial experience

TRC Johnson, B Krauss, M Sedlmair, M Grasruck… - European …, 2007 - Springer
The aim of this study was to assess the feasibility of a differentiation of iodine from other
materials and of different body tissues using dual energy CT. Ten patients were scanned on …

Treatment of breast cancer during pregnancy: an observational study

S Loibl, SN Han, G von Minckwitz, M Bontenbal… - The lancet …, 2012 - thelancet.com
Background Little is known about the treatment of breast cancer during pregnancy. We
aimed to determine whether treatment for breast cancer during pregnancy is safe for both …

The association between vitamin D receptor expression and prolonged overall survival in breast cancer

N Ditsch, B Toth, D Mayr, M Lenhard… - … of Histochemistry & …, 2012 - journals.sagepub.com
In this study, we analyzed vitamin D receptor (VDR) expression and survival in a breast
cancer patient cohort of 82 breast cancer patients. Immunohistochemical analysis was …

Human epididymis protein 4 (HE4) in benign and malignant diseases

L Hertlein, P Stieber, A Kirschenhofer… - Clinical Chemistry and …, 2012 - degruyter.com
Background: Human epididymis protein 4 (HE4) is described as a useful new biomarker in
ovarian cancer. As HE4 is neither tumor nor organ specific, we intensively investigated the …

Long-term follow-up after ovarian borderline tumor: relapse and survival in a large patient cohort

MS Lenhard, S Mitterer, C Kümper, P Stieber… - European Journal of …, 2009 - Elsevier
OBJECTIVES: To assess long-term survival and relapse rate of patients diagnosed with a
borderline tumor of the ovary (BOT) with special focus on the influence of primary surgery …

Thyroid function in breast cancer patients

N Ditsch, S Liebhardt, F Von Koch, M Lenhard… - Anticancer …, 2010 - ar.iiarjournals.org
Background: Recent studies indicate a possible relationship between hypothyroidism and
breast cancer in vivo. In addition, oestrogen-like effects of thyroid hormones on breast …

Phyllodes tumour of the breast: clinical follow-up of 33 cases of this rare disease

MS Lenhard, S Kahlert, I Himsl, N Ditsch… - European Journal of …, 2008 - Elsevier
OBJECTIVE: The “cystosarcoma phyllodes” of the breast is a rare entity which accounts for
0.5% of all breast neoplasms. The aim of our study was to analyse the clinical management …

Afamin and apolipoprotein A-IV: novel protein markers for ovarian cancer

H Dieplinger, DP Ankerst, A Burges, M Lenhard… - … Biomarkers & Prevention, 2009 - AACR
Comparative proteomics identified the vitamin E-binding plasma protein afamin as a
potential novel tumor marker for ovarian cancer. In addition, we observed in a previous small …

Breast cancer and pregnancy: challenges of chemotherapy

MS Lenhard, I Bauerfeind, M Untch - Critical Reviews in Oncology …, 2008 - Elsevier
BACKGROUND: Breast cancer is the second most frequently occurring malignancy during
pregnancy. As evidence-based data on diagnostics and treatment is lacking, current …

Pelvimetry revisited: analyzing cephalopelvic disproportion

MS Lenhard, TRC Johnson, S Weckbach… - European journal of …, 2010 - Elsevier
The objective of this study was to assess the clinical value of pelvimetry to predict dystocia
due to cephalopelvic disproportion. 63 patients who had received an abdominal CT scan …